Abstract
The article presents the text of the 2024 Clinical practice guidelines for Ebstein's anomaly approved by the Ministry of Health of the Russian Federation. It provides detailed data, principles, algorithms, and assessment scales concerning the etiology and pathogenesis, epidemiology, and classification of the disease. Also included are the clinical presentation, diagnosis, and methods of conservative and surgical treatment, rehabilitation, and dispensary observation (follow-up care). Criteria for assessing the quality of medical care are provided.
References
- Brown M.L., Dearani J.A., Danielson G.K., Cetta F., Connolly H.M., Warnes C.A. et al. Mayo Clinic Congenital Heart Center. The outcomes of operations for 539 patients with Ebstein anomaly. J. Thorac. Cardiovasc. Surg. 2008; 135 (5): 1120–1136, 1136.e1–7. DOI: 10.1016/j.jtcvs.2008.02.034
-
Bockeria L.A., Shatalov K.V. Pediatric сardiac surgery. Moscow; 2016: 294–312 (in Russ.).
-
Giamberti A., Chessa M. The tricuspid valve in congenital heart disease. Springer-Verlag Italia; 2014.
-
Bockeria L.A., Podzolkov V.P., Sabirov B.N. The Ebstein anomaly. Moscow; 2005: 151–206 (in Russ.).
-
Walsh E.P. Ebstein’s anomaly of the tricuspid valve: a Natural Laboratory for Re-Entrant Tachycardias. JACC Clin. Electrophysiol. 2018; 4 (10): 1271–1288. DOI: 10.1016/j.jacep.2018.05.024
-
Janson C.M., Shah M.J. Supraventricular tachycardia in adult congenital heart disease: mechanisms, diagnosis, and clinical aspects. Card. Electrophysiol Clin. 2017; 9 (2): 189–211. DOI: 10.1016/j.ccep.2017.02.005
-
Khairy P. Arrhythmias in adults with congenital heart disease: what the practicing cardiologist needs to know. Can. J. Cardiol. 2019; 35 (12): 1698–1707. DOI: 10.1016/j.cjca.2019.07.009
-
Mavroudis C., Dearani J.A. Atlas of adult congenital heart surgery. Springer Nature Switzerland AG; 2020.
-
Roten L., Lukac P., De Groot N., Nielsen J.C., Szili-Torok T., Jensen H.K. et al. Catheter ablation of arrhythmias in Ebstein’s anomaly: a multicenter study. J. Cardiovasc. Electrophysiol. 2011; 22 (12): 1391–1396. DOI: 10.1111/ j.1540-8167.2011.02161.x
-
Wackel P., Cannon B., Dearani J., Sessions K., Holst K., Johnson J., Cetta F. Arrhythmia after cone repair for Ebstein anomaly: the Mayo Clinic experience in 143 young patients. Congenit. Heart Dis. 2018; 13 (1): 26–30. DOI: 10.1111/chd.12566
-
Delhaas T., Sarvaas G.J., Rijlaarsdam M.E., Strengers J.L., Eveleigh R.M., Poulino S.E. et al. A multicenter, long-term study on arrhythmias in children with Ebstein anomaly. Pediatr. Cardiol. 2010; 31 (2): 229–233. DOI: 10.1007/s00246-009-9590-3
-
Raju V., Dearani J.A., Burkhart H.M., Grogan M., Phillips S.D., Ammash N. et al. Right ventricular unloading for heart failure related to Ebstein malformation. Ann. Thorac. Surg. 2014; 98 (1): 167–173; discussion 173–174. DOI: 10.1016/j.athoracsur.2014.03.009
-
Obioha-Ngwu O., Milliez P., Richardson A., Pittaro M., Josephson M.E. Ventricular tachycardia in Ebstein's Anomaly. Circulation. 2001; 104(18): E92–94. DOI: 10.1161/hc4301.098011
-
Shivapour J.K., Sherwin E.D., Alexander M.E., Cecchin F., Mah D.Y., Triedman J.K. et al. Tility of preoperative electrophysiologic studies in patients with Ebstein’s anomaly undergoing the Cone procedure. Heart Rhythm. 2014; 11 (2): 182–186. DOI: 10.1016/j.hrthm.2013. 10.045
- Kubuš P., Vít P., Gebauer R.A., Materna O., Janoušek J. Electrophysiologic profile and results of invasive risk stratification in asymptomatic children and adolescents with the Wolff-Parkinson-White electrocardiographic pattern. Circ. Arrhythm. Electrophysiol. 2014; 7 (2): 218–223. DOI: 10.1161/CIRCEP.113.000930
-
McIntosh N., Chitayat D., Bardanis M., Fouron J.C. Ebstein anomaly: report of a familial occurrence and prenatal diagnosis. Am. J. Med. Genet. 1992; 42 (3): 307–309. DOI: 10.1002/ajmg.1320420309
-
De Lonlay-Debeney P., de Blois M.C., Bonnet D., Amiel J., Abadie V., Picq M. et al. Ebstein anomaly associated with rearrangements of chromosomal region 11q. Am. J. Med. Genet. 1998; 80 (2): 157–159. DOI: 10.1002/(sici)1096-8628(19981102)80:2<157::aid- ajmg12>3.0.co;2-u
-
Digilio M.C., Bernardini L., Lepri F., Giuffrida M.G., Guida V., Baban A. et al. Ebstein anomaly: genetic heterogeneity and association with microdeletions 1p36 and 8p23.1. Am. J. Med. Genet. A. 2011; 155A (9): 2196–2202. DOI: 10.1002/ajmg.a.34131
-
Harvey R.P. NK-2 homeobox genes and heart development. Develop. Biol. 1996; 178 (2): 203–216. DO
I: 10.1006/dbio.1996.0212
-
Postma A.V., van Engelen K., van de Meerakker J. et al. Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ. Cardiovasc. Genet. 2011; 4 (1): 43–50. DOI: 10.1161/CIRCGENETICS.110.957985
-
Penyaeva E.V. Genetic aspects of Ebstein’s anomaly and related heart diseases. Vestnik RAMN. 2021; 76 (1): 67–74 (in Russ.).
-
Celermajer D.S., Cullen S., Sullivan I.D., Spiegelhalter D.J., Wyse R.K., Deanfield J.E. Outcome in neonates with Ebstein’s anomaly. J. Am. Coll. Cardiol. 1992; 19 (5): 1041–1046. DOI: 10.1016/0735-1097(92)90291-t
-
Burakovskiy V.I., Bockeria L.A. (Eds) Cardiovascular Surgery. Moscow; 1989 (in Russ.).
-
Lang D., Oberhoffer R., Cook A., Sharland G., Allan L., Fagg N., Anderson R.H. Pathologic spectrum of malformations of the tricuspid valve in prenatal and neonatal life. J. Am. Coll. Cardiol. 1991; 17 (5): 1161–1167. DOI: 10.1016/0735-1097(91)90848-4
-
Sharland G.K., Chita S.K., Allan L.D. Tricuspid valve dysplasia or displacement in intrauterine life. J. Am. Coll. Cardiol. 1991; 17 (4): 944–949. DOI: 10.1016/0735-1097(91)90877-c
-
Castaneda A.R., Jonas R.A., Mayer J.E., Hanley F.L. Ebstein’s anomaly. In: Cardiac surgery of the neonate and infant. 1994: 273–280.
-
Carpentier A., Chauvaud S., Macé L., Relland J., Mihaileanu S., Marino J.P. et al. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J. Thorac. Cardiovasc. Surg. 1988; 96 (1): 92–101.
-
Sano S., Fujii Y., Kasahara S., Kuroko Y., Tateishi A., Yoshizumi K., Arai S. Repair of Ebstein’s anomaly in neonates and small infants: impact of right ventricular exclusion and its indications. Eur. J. Cardiothorac. Surg. 2014; 45 (3): 549–555; discussion 555. DOI: 10.1093/ ejcts/ezt465
-
Mizuno M., Hoashi T., Sakaguchi H., Kagisaki K., Kitano M., Kurosaki K. et al. Application of cone reconstruction for neonatal Ebstein anomaly or tricuspid valve dysplasia. Ann. Thorac. Surg. 2016; 101 (5): 1811–1817. DOI: 10.1016/j.athoracsur.2015.11.029
-
Stout K.K., Daniels C.J., Aboulhosn J.A., Bozkurt B., Broberg C.S., Colman J.M. et al. 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: a Report of the American College of Cardiology / American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2019; 73 (12): e81–e192. DOI: 10.1016/j.jacc.2018.08.1029
Erratum in: J. Am. Coll. Cardiol. 2019; 73 (18): 2361–2362. DOI: 10.1016/j.jacc.2019.03.018
-
Baumgartner H., De Backer J., Babu-Narayan S.V., Budts W., Chessa M., Diller G.P. et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur. Heart J. 2021; 42 (6): 563–645. DOI: 10.1093/eurheartj/ehaa554
-
Bockeria L.A., Bockeria O.L., Sabirov B.N., Tetvadze I.V., Aleksandrova M.L., Chernogrivov I.E., Murzagaliev M.U. A modern approach and results of simultaneous correction of Ebstein’s anomaly and Wolf–Parkinson–White syndrome. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2012; 54 (1): 4–11 (in Russ.).
- Caldeira D., David C., Costa J., Ferreira J.J., Pinto F.J. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis. Eur. Heart J. Cardiovasc. Pharmacother. 2018; 4 (2): 111–118. DOI: 10.1093/ehjcvp/pvx028
- Bokeriya L.A., Golukhova E.Z., Revishvili A.Sh., Levant A.D., Dadasheva M.A., Dzhitava T.G. et al. A differentiated approach to surgical treatment of Ebstein’s anomaly combined with Wolf–Parkinson–White syndrome. Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2003; 2: 12–17 (in Russ.).
- Dolgov V.V. (Ed.). Clinical laboratory diagnostics. Moscow; 2016 (in Russ.).
- Brugada J., Katritsis D.G., Arbelo E., Arribas F., Bax J.J., Blomström-Lundqvist C. et al. ESC scientific document group. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur. Heart J. 2020; 41 (5): 655–720. DOI: 10.1093/eurheartj/ehz467
- Rodseth R.N., Biccard B.M., Le Manach Y., Sessler D.I., Lurati Buse G.A., Thabane L. et al. The prognostic value of pre-operative and post- operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro- B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J. Am. Coll. Cardiol. 2014; 63 (2): 170–180. DOI: 10.1016/j.jacc.2013.08.1630
- Lopes L.M., Damiano A.P., Moreira G.N., Azevedo T.J., Nagamatsu C.T., Tavares G.M. et al. The role of echocardiography as an isolated method for indicating surgery in patients with congenital heart disease. Arq. Bras. Cardiol. 2005; 84 (5): 381–386. DOI: 10.1590/s0066- 782x2005000500006
- Iturralde P., Nava S., Sálica G., Medeiros A., Márquez M.F., Colin L. et al. Electrocardiographic characteristics of patients with Ebstein’s anomaly before and after ablation of an accessory atrioventricular pathway. J. Cardiovasc. Electrophysiol. 2006; 17 (12): 1332–1336. DOI: 10.1111/j.1540-8167.2006.00617.x
- Danielson G.K., Fuster V. Surgical repair of Ebstein’s anomaly. Ann. Surg. 1982; 196 (4): 499–504. DOI: 10.1097/00000658-198210000- 00014
- Bockeria L.A. Tachyarrhythmias. Diagnosis and surgical treatment. Leningrad; 1989: 73–121 (in Russ.).
- DeWitt E.S., Beausejour-Ladouceur V., Whitehill R., Radiofrequency ablation versus medical therapy for first episode of atrial tachycardia in adults with congenital heart disease. Heart Rhythm. 2016; 13: S449.
- Park J.B., Lee S.P., Lee J.H., Yoon Y.E., Park E.A., Kim H.K. et al. Quantification of right ventricular volume and function using single-beat three-dimensional echocardiography: A validation study with cardiac magnetic resonance. J. Am. Soc. Echocardiogr. 2016; 29 (5): 392–401. DOI: 10.1016/j.echo.2016.01.010
- Kumor M., Lipczyńska M., Biernacka E.K., Klisiewicz A., Wójcik A., Konka M. et al. Cardiac arrest and ventricular arrhythmia in adults with Ebstein anomaly and left ventricular non-compaction. J. Cardiol. 2018; 71 (5): 484–487. DOI: 10.1016/j.jjcc.2017.11.012
- Chauvaud S.M., Brancaccio G., Carpentier A.F. Cardiac arrhythmia in patients undergoing surgical repair of Ebstein’s anomaly. Ann. Thorac. Surg. 2001; 71 (5): 1547–1552. DOI: 10.1016/s0003-4975(01)02464-x
- Kirklin J.W., Barratt-Boyes B.G. Cardiac surgery: morphology, diagnostic criteria, natural history, techniques, results, and indications. 4rd ed. N.Y.; 2013.
- Negoi R.I., Ispas A.T., Ghiorghiu I., Filipoiu F., Negoi I., Hostiuc M.E. et al. Complex Ebstein’s malformation: defining preoperative cardiac anatomy and function. J. Cardiac. Surg. 2013; 28 (1): 70–81. DOI:10.1111/jocs.12032
- Jentzer J.C., DeWald T.A., Hernandez A.F. Combination of loop diuretics with thiazide-type diuretics in heart failure. J. Am. Coll. Cardiol. 2010; 56 (19): 1527–1534. DOI: 10.1016/j.jacc.2010.06.034
- Rydman R., Shiina Y., Diller G.P., Niwa K., Li W., Uemura H. et al. Major adverse events and atrial tachycardia in Ebstein’s anomaly predicted by cardiovascular magnetic resonance. Heart. 2018; 104 (1): 37–44. DOI: 10.1136/heartjnl-2017-311274
- Ahmed S., Nanda N.C., Nekkanti R., Pacifico A.D. Transesophageal three-dimensional echocardiographic demonstration of Ebstein’s anomaly. Echocardiography. 2003; 20 (3): 305–307. DOI: 10.1046/j.1540-8175.2003.03034.x
- Van Noord P.T., Scohy T.V., McGhie J., Bogers A.J. Three-dimensional transesophageal echocardiography in Ebstein’s anomaly. Interact. Cardiovasc. Thorac. Surg. 2010; 10 (5): 836–837. DOI: 10.1510/icvts.2009.229476
- Filatov A.G., Goryachev V.A. The role of electrophysiological research in the choice of treatment tactics for the pathology of Ebstein’s anomaly in combination with an additional atrioventricular junction. Annaly Aritmologii. 2018; 15 (4): 220–224 (in Russ.). DOI: 10.15275/ annaritmol.2018.4.4
- Iturralde P., Nava S., Sálica G., Medeiros A., Márquez M.F., Colin L. et al. Electrocardiographic characteristics of patients with Ebstein’s anomaly before and after ablation of an accessory atrioventricular pathway. J. Cardiovasc. Electrophysiol. 2006; 17 (12): 1332–1336. DOI: 10.1111/j.1540-8167.2006.00617.x
- Zhu D., Chung H.F., Dobson A.J., Pandeya N., Giles G.G., Bruinsma F. et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet. Public. Health. 2019; 4 (11): e553–e564. DOI: 10.1016/S2468-2667(19)30155- 0
- Diller G.P., Dimopoulos K., Okonko D., Li W., Babu-Narayan S.V., Broberg C.S. et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005; 112 (6): 828–835. DOI: 10.1161/ CIRCULATIONAHA.104.529800
- Siân Pincott E., Burch M. Indications for heart transplantation in congenital heart disease. Curr. Cardiol. Rev. 2011; 7 (2): 51–58. DOI: 10.2174/157340311797484240
- Book W.M., Shaddy R.E. Medical therapy in adults with congenital heart disease. Heart Fail. Clin. 2014; 10 (1): 167–178. DOI: 10.1016/j.hfc.2013.09.006
- Diagnos i lechenie KhSN u detei i podrostkov. Metodicheskie rekomendatsii. Assotsiatsiya detskikh kardiologov. M.; 2010.
- Kantor P.F., Lougheed J., Dancea A., McGillion M., Barbosa N., Chan C. et al. Children’s Heart Failure Study Group. Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines. Can. J. Cardiol. 2013; 29 (12): 1535–1552. DOI: 10.1016/j.cjca.2013.08.008
- Priori S.G., Blomström-Lundqvist C. 2015 European Society of Cardiology Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. Eur. Heart J. 2015; 36 (41): 2757–2759. DOI: 10.1093/eurheartj/ehv445
- Budts W., Börjesson M., Chessa M., van Buuren F., Trigo Trindade P., Corrado D. et al. Physical activity in adolescents and adults with congenital heart defects: individualized exercise prescription. Eur. Heart J. 2013; 34 (47): 3669–3674. DOI: 10.1093/eurheartj/eht433
- Gheorghiade M., Patel K., Filippatos G., Anker S.D., van Veldhuisen D.J., Cleland J.G. et al. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial. Eur. J. Heart Fail. 2013; 15 (5): 551–559. DOI: 10.1093/eurjhf/hft010
- Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., Krumholz H.M. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003; 289 (7): 871–878. DOI: 10.1001/jama.289.7.871
- Bosnic Z. et al. Pathophysiological complexity of amiodarone-induced hypothyroidism (AIH) in patient with congenital heart disease – Ebstein anomaly: a case report. 2021. DOI: 10.21203/rs.3.rs-304220/v1
- Hernández-Madrid A., Paul T., Abrams D., Aziz P.F., Blom N.A., Chen J. et al. ESC Sc
ientific Document Group. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace. 2018; 20 (11): 1719
- Beaufort-Krol G.C., Dijkstra S.S., Bink-Boelkens M.T. Natural history of ventricular premature contractions in children with a structurally normal heart: does origin matter? Europace. 2008; 10 (8): 998–1003. DOI: 10.1093/europace/eun121
- Wang S., Zhu W., Hamilton R.M., Kirsh J.A., Stephenson E.A., Gross G.J. Diagnosis-specific characteristics of ventricular tachycardia in children with structurally normal hearts. Heart Rhythm. 2010; 7 (12): 1725–1731. DOI: 10.1016/j.hrthm.2010.07.037
- Collins K.K., Schaffer M.S., Liberman L., Saarel E., Knecht M., Tanel R.E. et al. Pediatric and Congenital Electrophysiology Society. Fascicular and nonfascicular left ventricular tachycardias in the young: an international multicenter study. J. Cardiovasc. Electrophysiol. 2013; 24 (6): 640–648. DOI: 10.1111/jce.12105
- Pappone C., Vicedomini G., Manguso F., Baldi M., Pappone A., Petretta A. et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation. 2012; 125 (5): 661–668. DOI: 10.1161/CIRCULATIONAHA.111.065722
- Renda G., Ricci F., Giugliano R.P., De Caterina R. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease. J. Am. Coll. Cardiol. 2017; 69 (11): 1363–1371. DOI: 10.1016/j.jacc.2016.12.038
- Roldán V., Marín F., Manzano-Fernández S., Gallego P., Vílchez J.A., Valdés M. et al. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. J. Am. Coll. Cardiol. 2013; 62(23): 2199–2204. DOI: 10.1016/j.jacc.2013.08.1623
- Khairy P., Van Hare G.F., Balaji S., Berul C.I., Cecchin F., Cohen M.I. et al. PACES/HRS Expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014; 11 (10): e102–165. DOI: 10.1016/j.hrthm.2014.05.009
- Ahmed H., VanderPluym C. Medi
